Literature DB >> 1398756

Lymphocytes bearing the gamma delta T-cell receptor in acute toxoplasmosis.

F Scalise1, R Gerli, G Castellucci, F Spinozzi, G M Fabietti, S Crupi, L Sensi, R Britta, R Vaccaro, A Bertotto.   

Abstract

Although the relative and absolute numbers of CD3+ cells (T lymphocytes) were similar in eight children with acquired Toxoplasma gondii infection and 10 uninfected age- and sex-matched healthy controls, the proportion of cells bearing the gamma delta T-cell receptor was significantly higher in the subjects with acute toxoplasmosis. The great majority of gamma delta T cells from the infected patients expressed covalently bound gamma delta chains on their surface, i.e. were BB3+ lymphocytes. Since the gamma delta T-cell subsets exert both restricted and unrestricted major histocompatibility complex cytotoxicity, further research is needed to elucidate the role of gamma delta T cells in the control of this coccidian protozoan infection.

Entities:  

Mesh:

Substances:

Year:  1992        PMID: 1398756      PMCID: PMC1421574     

Source DB:  PubMed          Journal:  Immunology        ISSN: 0019-2805            Impact factor:   7.397


  14 in total

Review 1.  The role of gamma delta T lymphocytes in infection.

Authors:  W K Born; K Harshan; R L Modlin; R L O'Brien
Journal:  Curr Opin Immunol       Date:  1991-08       Impact factor: 7.486

2.  Sequential appearance of gamma/delta- and alpha/beta-bearing T cells in the peritoneal cavity during an i.p. infection with Listeria monocytogenes.

Authors:  S Ohga; Y Yoshikai; Y Takeda; K Hiromatsu; K Nomoto
Journal:  Eur J Immunol       Date:  1990-03       Impact factor: 5.532

Review 3.  The gamma delta T cell receptor.

Authors:  M B Brenner; J L Strominger; M S Krangel
Journal:  Adv Immunol       Date:  1988       Impact factor: 3.543

4.  Early appearing gamma/delta-bearing T cells during infection with Calmétte Guérin bacillus.

Authors:  T Inoue; Y Yoshikai; G Matsuzaki; K Nomoto
Journal:  J Immunol       Date:  1991-04-15       Impact factor: 5.422

5.  Coordinated V gamma and V delta gene segment rearrangements in human T cell receptor gamma/delta+ lymphocytes.

Authors:  E Sturm; E Braakman; R E Bontrop; P Chuchana; R J Van de Griend; F Koning; M P Lefranc; R L Bolhuis
Journal:  Eur J Immunol       Date:  1989-07       Impact factor: 5.532

6.  Differential expression of CD45RO (UCHL1) and its functional relevance in two subpopulations of circulating TCR-gamma/delta+ lymphocytes.

Authors:  T Miyawaki; Y Kasahara; K Taga; A Yachie; N Taniguchi
Journal:  J Exp Med       Date:  1990-05-01       Impact factor: 14.307

7.  Preferential expansion of Ly-1 B and CD4- CD8- T cells in the polyclonal lymphocyte responses to murine T. cruzi infection.

Authors:  P Minoprio; A Bandeira; P Pereira; T Mota Santos; A Coutinho
Journal:  Int Immunol       Date:  1989       Impact factor: 4.823

8.  The vitronectin receptor serves as an accessory molecule for the activation of a subset of gamma/delta T cells.

Authors:  K Roberts; W M Yokoyama; P J Kehn; E M Shevach
Journal:  J Exp Med       Date:  1991-01-01       Impact factor: 14.307

9.  Selection by two powerful antigens may account for the presence of the major population of human peripheral gamma/delta T cells.

Authors:  G De Libero; G Casorati; C Giachino; C Carbonara; N Migone; P Matzinger; A Lanzavecchia
Journal:  J Exp Med       Date:  1991-06-01       Impact factor: 14.307

10.  The primary response of human gamma/delta + T cells to Mycobacterium tuberculosis is restricted to V gamma 9-bearing cells.

Authors:  D Kabelitz; A Bender; T Prospero; S Wesselborg; O Janssen; K Pechhold
Journal:  J Exp Med       Date:  1991-06-01       Impact factor: 14.307

View more
  28 in total

1.  The proportion of circulating gammadelta T cells increases after the first week of onset of tularaemia and remains elevated for more than a year.

Authors:  M Kroca; A Tärnvik; A Sjöstedt
Journal:  Clin Exp Immunol       Date:  2000-05       Impact factor: 4.330

Review 2.  Tissue distribution, antigen specificity and effector functions of gamma delta T cells in human diseases.

Authors:  G De Libero
Journal:  Springer Semin Immunopathol       Date:  2000

Review 3.  Antigen recognition by human gamma delta T cells: pattern recognition by the adaptive immune system.

Authors:  C T Morita; R A Mariuzza; M B Brenner
Journal:  Springer Semin Immunopathol       Date:  2000

Review 4.  Vgamma2Vdelta2+ T cells and anti-microbial immune responses.

Authors:  Zheng W Chen; Norman L Letvin
Journal:  Microbes Infect       Date:  2003-05       Impact factor: 2.700

Review 5.  Adaptive immune response of Vgamma2Vdelta2 T cells: a new paradigm.

Authors:  Zheng W Chen; Norman L Letvin
Journal:  Trends Immunol       Date:  2003-04       Impact factor: 16.687

6.  In vivo and in vitro activation and expansion of gammadelta T cells during Listeria monocytogenes infection in humans.

Authors:  F Jouen-Beades; E Paris; C Dieulois; J F Lemeland; V Barre-Dezelus; S Marret; G Humbert; J Leroy; F Tron
Journal:  Infect Immun       Date:  1997-10       Impact factor: 3.441

Review 7.  gamma/delta and other unconventional T lymphocytes: what do they see and what do they do?

Authors:  S H Kaufmann
Journal:  Proc Natl Acad Sci U S A       Date:  1996-03-19       Impact factor: 11.205

8.  Unilateral necrotising toxoplasmic retinochoroiditis as the main clinical manifestation of a peptide transporter (TAP) deficiency.

Authors:  A Parissiadis; A Dormoy; D Fricker; D Hanau; H de la Salle; J-P Cazenave; P Lenoble; L Donato
Journal:  Br J Ophthalmol       Date:  2005-12       Impact factor: 4.638

9.  Central nervous system toxoplasmosis with an increased proportion of circulating gamma delta T cells in a patient with hyper-IgM syndrome.

Authors:  L E Leiva; J Junprasert; D Hollenbaugh; R U Sorensen
Journal:  J Clin Immunol       Date:  1998-07       Impact factor: 8.317

10.  Human V delta 2+ gamma delta T-cell tolerance to foreign antigens of Toxoplasma gondii.

Authors:  T Hara; S Ohashi; Y Yamashita; T Abe; H Hisaeda; K Himeno; R A Good; K Takeshita
Journal:  Proc Natl Acad Sci U S A       Date:  1996-05-14       Impact factor: 11.205

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.